• Archives of Plastic Surgery
• /
• 제35권3호
• /
• pp.235-242
• /
• 2008

Purpose: Due to increasing interest in the treatment of spinal cord injuries, many histopathological studies have been conducted to prove that many neurotrophic factors including growth hormone are important for regeneration of the injured spinal cord. Growth hormone has to be given everyday, however, and this negatively affects compliance in clinical trials. Recently, the invention of sustained release growth hormone (SRGH) that can be given just once a week may both help the regeneration of injured spinal cord and, at the same time, be more compliant and convenient for clinical patients. Methods: In this study, thirty 7-week-old female Spraque-Dawley rats were subjected to a weight-driven impact spinal cord injury. They were divided into 3 groups and Group I and II were injected with SRGH once a week for 4 weeks; Group I were injected into the injured spinal cord area, while Group II were injected into the peritoneal cavity. Meanwhile, Group III were injected with normal saline solution. The functional outcome was evaluated using the Basso-Beattie-Bresnahan motor rating score and the inclined plane test was done 4 weeks after the first injection. Histopathological examination was performed at the same time and the amount of residual white matter was measured in all groups. Results: After 4 weeks, Groups I and II showed greater improvement than Group III(the control group) in the functional test. In the control group, invasion of atypical phagocytes, axonal degeneration, edema and cavity formation in the posterior site of spinal cord gray matter was observed in histopatholgical examination. The rate of residual white matter in Group III was less than in the other groups. Conclusion: Data showed significant functional and histopathological improvement in the groups treated with SRGH into the spinal and peritoneal cavity compared with the control group. SRGH is therefore beneficial because it helps with regeneration of the injured spinal cord and improves the compliance and convenience of patients.

• 대한후두음성언어의학회지
• /
• 제12권1호
• /
• pp.46-54
• /
• 2001

Background and Objectives : Nitric oxide(NO) is a short-lived molecule with messenger and cytotoxic functions in nervous, cardiovascular, and immune systems. Among the three distinct NOS isoforms, the neuronal isoform is expressed in small, discrete neuronal populations of CNS and PNS. Axonal injury in adult animals results in a dramatic NOS up-regulation in many types of central and peripheral neurons which normally lack the enzyme or express it only at very low levels. In previous study, we confirmed the efficacy of PEMS on the early functional recovery in rats with surgically transected and reanastomosed recurrent laryngeal nerve. Therefore, after we obtained functionally recovered rats using PEMS in this study, we studied to evaluate the expression of nNOS through the analysis of the difference between functional recovery group and non-recovery group in the recurrent laryngeal nerve. Materials and Method : Using 84 healthy male Sprague-Dawley rats, transections and primary anastomosis were performed on their left recurrent laryngeal nerves. Rats were then randomly assigned to 2 groups. The rats in group A(n=42) received PEMS by placing them in custom cages equipped with Helm-holz coils(3 hr/day, 5 days/wk, for 12 wk). The rats in group B(n=42) were handled the same way as the group A, except that they did not receive PEMS. Laryngovideoendoscopy was performed before and after surgery and followed up weekly. Laryngeal EMG was obtained in both PCA and TA muscles. Immunohistochemisty staining using monoclonal anti-neuronal nitric oxide synthase(nNOS) antibody was performed to detect nNOS in recurrent laryngeal nerve and nodose ganglion. Results : 20 rats(63%) in group A and 5 rats(17%) in the group B showed recovery of vocal fo1d motion. The number of NOS-positive cells was increased in functionally-recovered rats. NOS-staining intensity was reduced 12 weeks after nerve injury. The difference between PEMS group and non-stimulated group was not found. Conclusion : This study shows that nNOS may exert a beneficial effect on nerve regeneration and functional repair.

• Investigative Magnetic Resonance Imaging
• /
• 제18권4호
• /
• pp.290-302
• /
• 2014

목적: 자화율 강조 자기공명영상 (Susceptibility-weighted imaging)은 혈액분해산물, 석회화, 철 침착물을 발견하는데 있어 높은 민감도를 보이는 3D spoiled gradient-echo pulse sequence 이다. 본 임상화보는 자화율 강조 자기공명영상의 주된 임상적 적용에 대해 설명하고 논의하는 데에 그 목적이 있다. 대상과 방법: 자화율 강조 자기공명영상은 자기강도영상 (magnitude image)과 위상영상 (phase image)을 이용한 고해상도, 3D fully velocity-compensated gradient-echo sequence 에 기초를 두고 있다. 정맥 구조물의 가시성을 향상시키기 위해, 자기강도영상은 여과된 위상 데이터 (phase data) 로부터 발생된 위상 마스크 (phase mask)를 이용해 증폭되고, 이것은 최소강도투사 (Minimal intensive projection) 알고리즘을 이용한 3D dataset 후처리 과정을 거치게 된다. 3T 자기공명기기에서 SWI를 포함하는 자기공명영상 검사를 시행한 총 200명의 환자를 대상으로 연구하였다. 결과: 자화율 강조 자기공명영상은 다양한 뇌 질환의 발견에 매우 유용하였다. 200명의 환자 중 80명은 선천성 정맥 기형, 22명은 해면상 혈관종, 12명은 다양한 질환에서의 석회화, 21명은 혈관자화 징후 (susceptibility vessel sign) 또는 미세출혈을 동반하는 뇌혈관 질환, 52명은 뇌종양, 2명은 미만성 축삭 손상, 3명은 동정맥 기형, 5명은 뇌경막 동정맥루, 1명은 모야모야병, 그리고 2명은 파킨슨병이 관찰되었다. 결론: 자화율 강조 자기공명영상은 미세 저혈량 혈관성 병변, 석회화 그리고 미세출혈과 다양한 뇌병변의 진단에 유용하다.

• 대한임상검사과학회지
• /
• 제53권2호
• /
• pp.151-157
• /
• 2021

선천성 유전질환인 CMT와 후천성 면역 매개 질환인 CIDP는 임상적 증상이 유사하므로 두 질환의 감별진단을 위해서는 말초신경의 전기생리학적 특징을 비교하는 것이 도움이 될 수 있다. 본 연구는 CIDP와 CMT 1형으로 확진된 환자의 신경전도검사 결과 중 감각신경전도검사의 주요 지표별 결과를 후향적으로 정량분석하여 두 질환군의 전기생리학적 특징을 규명하고자 하였다. CIDP (N=35)와 CMT1 (N=30)로 확진된 환자의 dCNAP와 SNCV를 이용하여 두 질환군의 중증도 분석, 유의성 검정, 비정상 범위별 비율분석 및 상관분석을 실시하여 통계적 차이를 기반으로 특징을 비교하였다. 두 질환 모두 전신성 말초신경다발신경병증의 특징이 관찰되었고, 장딴지신경의 손상이 가장 심한 것으로 확인되었다. CMT1군은 탈수초성 및 축삭성 신경병증을 동반하는 전신성 신경병증이고, CIDP보다 더 중증의 신경병증임이 확인되었다. 또한, 상관계수 및 산점도 분석에서 CMT1은 신경 손상 범위가 전체 신경에서 균등한 전기생리학적 특징이 관찰되었다. 감각신경전도검사의 결과를 기반으로한 본 연구결과가 CIDP와 CMT 1형의 감별진단 및 연구에 도움이 될 것으로 사료된다.